Efficacy and safety of rituximab, high-dose methotrexate, and thiotepa (R-MT) as first-line induction therapy for primary central nervous system diffuse large B-cell lymphoma
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Haotian Wang, Jia Li, Xingtong Wang, Luming Cao, Chengqian Chen, Xin Wan, Ying Zhang, Zhaoxia Li, Jihong Xu, Panpan Yan, Yueyue Wen, Yang Song, Ou Bai
Institution: First Hospital of Jilin University
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7108613117
Cites:
Cited by:
Related to: